New York, April 7 (IANS) US researchers have developed new Artificial Intelligence (AI)-powered symptom checkers that can self-assess Covid-19 risk and potentially reduce the number of people going to in-person clinics during the pandemic.Covid symptom checkers, developed by the University of California, San Francisco (UCSF), use AI to help users identify their level of Covid-19 risk and assess whether they need to seek urgent care based on their reported symptoms. The tool is fully integrated with the users' medical records, allowing for immediate appointment scheduling.It also aims to provide reassurance to people who are experiencing symptoms that are not Covid-19 related, the researchers said, in the paper published in the journal BMJ Innovations."Symptom checkers have the potential to reduce the burden on health-care systems and the risk of person-to-person infection, so we wanted to find out how to improve these platforms so more people use them," said lead researcher Stephanie Aboueid, from the UCSF School of Public Health and Health Systems. For the study, 22 university students were interviewed in winter and spring of 2020. Nine of them did not know the tools exist. The researchers also conducted a survey on general symptom checkers in winter 2021, and data suggested 88 per cent (1,365 out of 1,545) of participants did not use one in the past year.The UCSF tool was able to reduce the number of visits while taking into account underlying conditions along with the symptom checks and booking follow-up appointments when needed.--IANSrvt/bg
Lucknow, March 23 (IANS) A Lucknow-based doctor has become the first person in Uttar Pradesh to test positive for Covid even after completing the two-dose course of the vaccine.Nitin Mishra, emergency medical officer at the Civil hospital, had been vaccinated with Covaxin on February 15 and then March 16.However, he developed a severe cough along with mild fever on March 18 and got himself tested on March 20.The report on Sunday revealed he was Covid19 positive and has isolated himself at home because he has only mild symptoms and regularly monitors his blood pressure and blood oxygen levels.Subhash Chandra Sundariyal, director, Civil hospital, said that, "We are also in touch with him and in case, symptoms aggravate, he will be hospitalized. The entire hospital has been sanitized and services are continuing as usual."Meanwhile, director general of medical health, D.S. Negi confirmed that Nitin Mishra's case is the first recorded instance where a person has been found to have contracted Covid-19 and turned symptomatic after completion of the two-dose course of Covaxin.Covaxin has been indigenously developed in India by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).Negi said "Data shows that the efficacy of Covaxin is about 80-90 per cent. The vaccine does not act as a shield against infection, but protects a person from falling critically ill, hence people should go for the vaccine, if they are medically eligible, without any hesitation."Prof Amita Jain, head of the microbiology department in King George's Medical University, said "It takes a few weeks, even after completion of the vaccination course, to build full immunity against the disease. During this period, a person may get infected and develop symptoms."--IANSamita/in
Shimla- A doctor in Himachal Pradesh tested positive for coronavirus after 27 days of the second dose of the vaccine, officials said on Saturday.
The woman doctor is posted in the Regional Hospital in Solan town.
District Health Officer Mukta Rastogi told the media the doctor had developed the coronavirus symptoms 27 days after getting the second dose of the vaccine.
She was administered the first dose of the vaccine on January 15, the first to get inculcated in the district.
Her samples will be sent to a Mumbai lab to ascertain the cause and to rule out the presence of any mutant strain," Rastogi added. (IANS)
Ministry of AYUSH has formed an Inter-disciplinary AYUSH R&D Task Force chaired by Prof. Bhushan Patwardhan and having representation from scientists including Indian Council of Medical Research (ICMR), Department of Biotechnology(DBT), Council of Scientific and Industrial Research (CSIR), All India Institute of Medical Sciences (AIIMS) and AYUSH Institutions.
The Interdisciplinary AYUSH Research and Development Task Force has formulated and designed clinical research protocols for prophylactic studies and add-on interventions in COVID-19 positive cases through thorough review and consultative process of experts of high repute from different organizations across the country for studying four different interventions viz.
Ashwagandha, Yashtimadhu, Guduchi + Pippali and a poly herbal formulation (AYUSH-64).The task force have taken up the proposals received from screening committees of Councils and proactively explored possibilities based on available leads.
Ministry of AYUSH has constituted core group of experts under the Chairmanship of Prof. Bhushan Patwardhan to identify and propose formulations on COVID-19 which are in line with Classical Ayurveda principles and have substantial leads on COVID-19 viz. one for prophylaxis as immunomodulatory, another for management of COVID-19 with antiviral properties and one product for post COVID-19 care.
Ministry of AYUSH has launched interdisciplinary studies involving AYUSH interventions for COVID-19 based on recommendations of Task force. Under various research organizations and National Institutes under Ministry of AYUSH, 112 research studies at 141 centres in the country are being conducted on AYUSH interventions as prophylactic interventions.
AYUSH Sanjivani mobile app developed by Ministry of AYUSH and has documented the impact assessment of effectiveness, acceptance and usage of AYUSH advisories & measures in the prevention of COVID-19 through Mobile app base population study in around 1.5 crores respondents. 85.1% of the respondents reported use of AYUSH measures for prevention of COVID-19, among which 89.8% respondents agreed to have benefitted from the practice of AYUSH advisory.
The Ministry of AYUSH has released “National Clinical Management Protocol based on Ayurveda and Yoga for management of COVID-19” prepared by National Task force which in consensus from expert committees from All India Institute of Ayurveda (AIIA), Delhi, Institute of Post Graduate Training and Research in Ayurved (IPGTRA), Jamnagar, and National Institute of Ayurveda (NIA), Jaipur , Central Council for Research in Ayurveda (CCRAS), Central Council for Research in Yoga and Naturopathy (CCRYN) and other national research organizations as per the Report & Recommendations of the Interdisciplinary Committee.
The Minister of State (The Ministry of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homeopathy), Sh. Kiren Rijiju (Additional Charge) stated this in a written reply in the Rajya Sabha here today.
Read More► Promotion of Ayurvedic Medicines in the country
The National Medicinal Plants Board (NMPB), Ministry of AYUSH has initiated a special drive to identify the patentable projects which were / are sponsored under the ‘Research and Development Component’ of Central Sector Scheme (CSS) on “Conservation, Development and Sustainable Management of Medicinal Plants”. NMPB generally sponsors various R&D programs under CSS to both government as well as private organizations across the country.
Under these sponsored / financially supported research projects, NMPB so far identified three unique projects which are novel in nature and patentable. They are: (1.) Bio-production of secondary metabolites from Aegle marmelos which is commonly known as Bel (R&D/TN-04/2006-07); (2.) In vitro production of secondary metabolites from tree species of Dashmoola (10 roots used in Ayurveda) through hairy root cultures (R&D/TN-0112013-14-NMPB); and (3.) Development of anti-cancer and anti-inflammatory agents from Dioscoria floribunda (R&D/UP-04/2015-16). While the first two projects belong to the Institute of Forest Genetics and Tree Breeding (IFGTB), Coimbatore, the third project was carried out by Central Institute of Medicinal and Aromatic Plants (CIMAP), Lucknow. The CIMAP filed patent is titled as “A synergistic polyherbal formulation exhibiting potential cancer activity.”
The CEO-NMPB reiterated that this is just the humble beginning for NMPB’s team and will file more patents in the coming times. The Secretary, Ministry of AYUSH congratulated the NMPB team for filing three patent applications in collaboration with the partner organizations. (Source - PIB)
पणजी| कर्नाटक में सड़क दुर्घटना में गंभीर रूप से घायल होने के एक महीने बाद, केंद्रीय रक्षा राज्य मंत्री श्रीपद नाइक को बुधवार को यहां के एक सरकारी अस्पताल से छुट्टी दे दी गई। राज्य के सर्वोच्च स्वास्थ्य सुविधा, गोवा मेडिकल कॉलेज के डीन डॉ. शिवानंद बंडोदकर ने पत्रकारों से कहा कि नाइक के घाव अच्छे से ठीक हो गए हैं और वह संसद के बजट सत्र में भाग लेने की स्थिति में हो सकते हैं, जोकि एक ब्रेक के बाद मार्च में आयोजित किया जाएगा।
बंडोदकर ने केंद्रीय मंत्री के छुट्टी के समय संवाददाताओं से कहा, "वह अच्छी तरह से ठीक हो गए हैं। उनकी जांघ की हड्डी का फ्रैक्च र भी ठीक हो गया है। उन्हें आराम की जरूरत है, जिसे वह घर पर कर सकते हैं।"
शीर्ष स्वास्थ्य अधिकारी ने कहा, "हम एक बार एक्स-रे करेंगे और उसकी स्थिति की जांच करने के बाद, हम उन्हें (संसद में भाग लेने के लिए) अनुमति देने पर विचार करेंगे। उनके स्वास्थ्य को ध्यान में रखते हुए, वह इसमें शामिल हो सकते हैं, लेकिन हम केवल एक्स-रे जांच के बाद ही कुछ कह पाएंगे।"
नाइक अपनी पत्नी और एक सहयोगी के साथ 12 जनवरी को कार से उत्तर कन्नड़ जिले में एक प्राइवेट विजिट पर जा रहे थे। इस दौरान उनकी कार यल्लापुरा के पास पलट गई। दुर्घटना में उनकी पत्नी और एक सहयोगी की मौत हो गई।
नाइक को अस्पताल से बाहर निकालते समय पत्रकारों से बात करते हुए, केंद्रीय मंत्री के बेटे सिद्धेश ने प्रधानमंत्री नरेंद्र मोदी, रक्षा मंत्री राजनाथ सिंह, मुख्यमंत्री प्रमोद सावंत को उनकी सहायता के लिए धन्यवाद दिया। (एजेंसी)
यह अंग्रेज़ी में भी पढ़ें► Union MoS Defence Shripad Naik Discharged a Month After a Road Accident